All six episodes of A Knight of the Seven Kingdoms are now available on HBO, while for more Game of Thrones action, here’s ...

HBO renewed the "Thrones" spinoff for Season 2 in November 2025, ahead of the series' debut. But what will that sophomore season look like? Read on for everything we know so far about "A Knight of the ...

Hell’s Paradise Season 2 Episode 7 felt like standing at the rim of a slow-burning volcano, where every clash promised either purification or collapse. Lord Tao Fa Tensen’s cold logic and the fragile ...

The Astros aren't sure whether Pearson will be able to appear in Grapefruit League games, pointing to a likely stint on the injured list to begin the season. Pearson will be stretched out as a ...

In the upcoming week, investor attention will focus on fallout from the Supreme Court's tariff ruling, tensions in Iran, and ...

Eli Lilly and Company (NYSE: LLY) is one of the best growth stocks to buy for the next 20 years. On February 18, Eli Lilly ...

Combination ixekizumab plus tirzepatide outperformed ixekizumab monotherapy for the treatment of both psoriasis and overweight or obesity, according to topline results announced by Eli ...

US drugmaker Eli Lilly has announced positive topline results from the landmark TOGETHER-PsO open-label Phase IIIb trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) ...

Eli Lilly's latest trial results and new licensing agreement show promise in treating psoriasis, obesity, and kidney disease.

At 36 weeks in the TOGETHER-PsO study, concomitant Taltz and Zepbound met primary endpoint of superiority vs. Taltz monotherapy in achieving complete skin clearance ...

Eli Lilly (LLY) stock is in focus as Zepbound succeeds in a late-stage trial for patients with plaque psoriasis. Read more ...